Christine Mauz-Körholz Selected Research

Christine Mauz-Körholz Research Topics

18	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 08/2006
6	Neoplasms (Cancer) 02/2018 - 01/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 07/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 02/2018 - 11/2011
2	Lymphoma (Lymphomas) 02/2018 - 01/2014
2	Mycoses (Diseases, Fungus) 08/2010 - 04/2010
1	Leukemia 01/2014
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 04/2012
1	Osteopetrosis 04/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2011
1	Chromosome Breakage 11/2011
1	Ataxia (Dyssynergia) 11/2011
1	Nijmegen Breakage Syndrome 11/2011
1	Pathologic Complete Response 08/2010
1	Melanoma (Melanoma, Malignant) 07/2008
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2004
1	Neoplasm Metastasis (Metastasis) 01/2004

5	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2004
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 08/2010
3	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 08/2010
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2010
3	Procarbazine (Matulane)FDA Link 01/2022 - 08/2010
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2018 - 09/2011
2	Dacarbazine (DIC)FDA LinkGeneric 05/2015 - 08/2010
2	Pharmaceutical PreparationsIBA 08/2006 - 01/2004
1	Circulating Tumor DNAIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Brentuximab VedotinIBA 02/2018
1	Rituximab (Mabthera)FDA Link 02/2018
1	Immunoconjugates (Immunoconjugate)IBA 02/2018
1	Immune Checkpoint InhibitorsIBA 02/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Complement Factor B (Factor B)IBA 01/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2014
1	Complementary DNA (cDNA)IBA 01/2014
1	Dual-Specificity PhosphatasesIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 11/2013
1	defibrotideIBA 04/2012
1	Voriconazole (Vfend)FDA LinkGeneric 08/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2008
1	AntigensIBA 07/2008
1	Dihydrotachysterol (AT 10)IBA 07/2007
1	Glucose (Dextrose)FDA LinkGeneric 08/2006
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2004
1	CaspasesIBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004

11	Drug Therapy (Chemotherapy) 10/2018 - 01/2004
6	Therapeutics 02/2018 - 01/2004
4	Radiotherapy 01/2022 - 01/2015
2	Aftercare (After-Treatment) 01/2022 - 09/2015
2	Hematopoietic Stem Cell Transplantation 01/2020 - 01/2020
1	Consolidation Chemotherapy 01/2022
1	Salvage Therapy 01/2020
1	Immunotherapy 01/2019
1	Induction Chemotherapy 10/2018
1	Organ Transplantation 01/2017
1	Stem Cell Transplantation 04/2012